CUSIP: G8028L107
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
34,219,644
-
Share change
-
+1,715,243
-
Total reported value
-
$353,275,266
-
Price per share
-
$10.33
-
Number of holders
-
64
-
Value change
-
+$18,055,229
-
Number of buys
-
20
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP G8028L107?
CUSIP G8028L107 identifies LGST - TEVOGEN BIO HLDGS INC COM - Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP G8028L107:
Institutional Holders of TEVOGEN BIO HLDGS INC COM - Stock (LGST) as of Q4 2022
As of 31 Dec 2022,
TEVOGEN BIO HLDGS INC COM - Stock (LGST) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,219,644 shares.
The largest 10 holders included
Saba Capital Management, L.P., FourWorld Capital Management LLC, Corbin Capital Partners, L.P., Calamos Advisors LLC, Polar Asset Management Partners Inc., MILLENNIUM MANAGEMENT LLC, Weiss Asset Management LP, HSBC HOLDINGS PLC, Radcliffe Capital Management, L.P., and Westchester Capital Management, LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.